| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |